AG˹ٷ

STOCK TITAN

[Form 4] Elanco Animal Health Incorporated Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) has received a Form 144 notice indicating that insider Phillip Carrai intends to sell up to 6,000 common shares on or about July 15, 2025 through Morgan Stanley Smith Barney. Based on the filing’s reference price, the transaction is valued at approximately $308,503.20.

The shares, originally issued as restricted stock on January 4, 2022, represent roughly 0.004 % of the company’s 153,443,342 shares outstanding—an amount too small to affect float or liquidity. The filing also details insider sales over the previous three months: 6,000 shares on June 16, 2025 for $252,967.20 and 6,000 shares on May 15, 2025 for $202,356.00, bringing Carrai’s disclosed sales to 18,000 shares this quarter.

  • Broker: Morgan Stanley Smith Barney LLC, New York.
  • Exchange: NASDAQ.
  • Relationship to issuer: Not specified in the filing text.

Form 144 serves only as advance notice; the transaction has not yet occurred. Given the small size relative to total shares, the filing is unlikely to exert meaningful market pressure, but it offers insight into recent insider sentiment.

Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) ha ricevuto un avviso Form 144 che indica l'intenzione dell'insider Phillip Carrai di vendere fino a 6.000 azioni ordinarie intorno al 15 luglio 2025 tramite Morgan Stanley Smith Barney. In base al prezzo di riferimento del deposito, la transazione vale circa 308.503,20 $.

Le azioni, originariamente emesse come azioni ristrette il 4 gennaio 2022, rappresentano circa lo 0,004 % delle 153.443.342 azioni in circolazione della società, una quantità troppo piccola per influenzare il flottante o la liquidità. Il deposito dettaglia anche le vendite degli insider negli ultimi tre mesi: 6.000 azioni il 16 giugno 2025 per 252.967,20 $ e 6.000 azioni il 15 maggio 2025 per 202.356,00 $, portando le vendite dichiarate di Carrai a 18.000 azioni in questo trimestre.

  • Broker: Morgan Stanley Smith Barney LLC, New York.
  • Borsa: NASDAQ.
  • Rapporto con l'emittente: Non specificato nel testo del deposito.

Il Form 144 serve solo come preavviso; la transazione non è ancora avvenuta. Data la piccola entità rispetto al totale delle azioni, il deposito difficilmente eserciterà una pressione significativa sul mercato, ma offre un'indicazione sul sentimento recente degli insider.

Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) ha recibido un aviso Formulario 144 que indica que el insider Phillip Carrai tiene la intención de vender hasta 6.000 acciones ordinarias alrededor del 15 de julio de 2025 a través de Morgan Stanley Smith Barney. Según el precio de referencia del formulario, la transacción está valorada en aproximadamente 308.503,20 $.

Las acciones, originalmente emitidas como acciones restringidas el 4 de enero de 2022, representan aproximadamente el 0,004 % de las 153.443.342 acciones en circulación de la compañía, una cantidad demasiado pequeña para afectar el flotante o la liquidez. El formulario también detalla ventas de insiders en los últimos tres meses: 6.000 acciones el 16 de junio de 2025 por 252.967,20 $ y 6.000 acciones el 15 de mayo de 2025 por 202.356,00 $, sumando ventas declaradas de Carrai por 18.000 acciones en este trimestre.

  • Corredor: Morgan Stanley Smith Barney LLC, Nueva York.
  • Bolsa: NASDAQ.
  • Relación con el emisor: No especificada en el texto del formulario.

El Formulario 144 sirve solo como aviso previo; la transacción aún no ha ocurrido. Dado el pequeño tamaño en relación con el total de acciones, es poco probable que el formulario ejerza una presión significativa en el mercado, pero ofrece una visión sobre el sentimiento reciente de los insiders.

Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS)� 내부� Phillip Carrai가 Morgan Stanley Smith Barney� 통해 2025� 7� 15일경 최대 6,000� 보통�� 매도� 계획임을 알리� Form 144 통지� 받았습니�. 제출서류� 기준가격에 따르� � 거래 가치는 � 308,503.20 달러� 평가됩니�.

� 주식들은 원래 2022� 1� 4� 제한주식으로 발행되었으며, 회사� � 발행 주식� 153,443,342� � � 0.004%� 해당하는 소량으로, 유통 주식수나 유동성에 � 영향� 미치지 않습니다. 제출서류에는 최근 3개월� 내부� 매도 내역� 포함되어 있습니다: 2025� 6� 16일에 6,000�(252,967.20 달러), 2025� 5� 15일에 6,000�(202,356.00 달러) 매도하여 이번 분기 Carrai가 공개� 매도 주식은 � 18,000�입니�.

  • 중개�: Morgan Stanley Smith Barney LLC, 뉴욕.
  • 거래�: NASDAQ.
  • 발행인과� 관�: 제출서류� 명시되지 않음.

Form 144� 사전 통지� 불과하며, 거래� 아직 이루어지지 않았습니�. 전체 주식 대� 규모가 작아 시장� � 영향� 미칠 가능성은 낮지�, 최근 내부자의 심리� 엿볼 � 있는 자료입니�.

Kratos Defense & Security Solutions, Inc. (NASDAQ : KTOS) a reçu un avis Formulaire 144 indiquant que l'initié Phillip Carrai a l'intention de vendre jusqu'à 6 000 actions ordinaires aux alentours du 15 juillet 2025 via Morgan Stanley Smith Barney. Selon le prix de référence du dépôt, la transaction est évaluée à environ 308 503,20 $.

Les actions, initialement émises en tant qu'actions restreintes le 4 janvier 2022, représentent environ 0,004 % des 153 443 342 actions en circulation de la société, un montant trop faible pour affecter le flottant ou la liquidité. Le dépôt détaille également les ventes des initiés au cours des trois derniers mois : 6 000 actions le 16 juin 2025 pour 252 967,20 $ et 6 000 actions le 15 mai 2025 pour 202 356,00 $, portant les ventes déclarées de Carrai à 18 000 actions ce trimestre.

  • Intermédiaire : Morgan Stanley Smith Barney LLC, New York.
  • Bourse : NASDAQ.
  • Relation avec l'émetteur : Non spécifiée dans le texte du dépôt.

Le Formulaire 144 sert uniquement d'avis préalable ; la transaction n'a pas encore eu lieu. Étant donné la faible taille par rapport au total des actions, le dépôt est peu susceptible d'exercer une pression significative sur le marché, mais il offre un aperçu du sentiment récent des initiés.

Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) hat eine Form 144-Mitteilung erhalten, die darauf hinweist, dass Insider Phillip Carrai beabsichtigt, bis zu 6.000 Stammaktien etwa am 15. Juli 2025 über Morgan Stanley Smith Barney zu verkaufen. Basierend auf dem Referenzpreis der Meldung wird die Transaktion auf etwa 308.503,20 $ äٳ.

Die Aktien, ursprünglich als Restricted Stock am 4. Januar 2022 ausgegeben, machen etwa 0,004 % der 153.443.342 ausstehenden Aktien des Unternehmens aus � eine Menge, die zu gering ist, um den Streubesitz oder die Liquidität zu beeinflussen. Die Meldung enthält auch Insider-Verkäufe der letzten drei Monate: 6.000 Aktien am 16. Juni 2025 für 252.967,20 $ und 6.000 Aktien am 15. Mai 2025 für 202.356,00 $, womit Carrais gemeldete Verkäufe in diesem Quartal 18.000 Aktien betragen.

  • Makler: Morgan Stanley Smith Barney LLC, New York.
  • ö: NASDAQ.
  • Beziehung zum Emittenten: Im Meldungstext nicht angegeben.

Form 144 dient nur als Vorabmitteilung; die Transaktion hat noch nicht stattgefunden. Aufgrund der geringen Größe im Verhältnis zur Gesamtzahl der Aktien ist es unwahrscheinlich, dass die Meldung nennenswerten Marktdruck ausübt, bietet jedoch Einblick in die jüngste Insider-Stimmung.

Positive
  • None.
Negative
  • Continued insider selling: Phillip Carrai has disclosed plans to sell another 6,000 shares after already divesting 12,000 shares in the past three months, which some investors may interpret as a mildly negative sentiment signal.

Insights

TL;DR: 6,000-share Form 144 filing is routine; immaterial to KTOS valuation.

The proposed sale equates to roughly 0.004 % of outstanding shares—an immaterial amount that should not influence supply-demand dynamics or earnings per share. Aggregate value of $309 k is negligible against KTOS’s multi-billion-dollar market cap. Insider transactions can hint at sentiment, yet Carrai’s modest position trimming after prior 6 k-share sales in May and June appears more like liquidity management than a signal of deteriorating fundamentals. Overall impact on investors is neutral.

TL;DR: Routine compliance disclosure; continued but minor insider selling warrants monitoring.

Form 144 filings uphold transparency by alerting markets to planned insider disposals. Carrai’s cumulative 18,000-share sales this quarter stay well below Rule 144 volume limits (1 % of shares outstanding or average weekly volume). Absence of a 10b5-1 plan date suggests discretionary timing, yet the amounts filed remain far from levels typically viewed as a governance red flag. While repeated sales can shape perception, no material governance concern arises here.

Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) ha ricevuto un avviso Form 144 che indica l'intenzione dell'insider Phillip Carrai di vendere fino a 6.000 azioni ordinarie intorno al 15 luglio 2025 tramite Morgan Stanley Smith Barney. In base al prezzo di riferimento del deposito, la transazione vale circa 308.503,20 $.

Le azioni, originariamente emesse come azioni ristrette il 4 gennaio 2022, rappresentano circa lo 0,004 % delle 153.443.342 azioni in circolazione della società, una quantità troppo piccola per influenzare il flottante o la liquidità. Il deposito dettaglia anche le vendite degli insider negli ultimi tre mesi: 6.000 azioni il 16 giugno 2025 per 252.967,20 $ e 6.000 azioni il 15 maggio 2025 per 202.356,00 $, portando le vendite dichiarate di Carrai a 18.000 azioni in questo trimestre.

  • Broker: Morgan Stanley Smith Barney LLC, New York.
  • Borsa: NASDAQ.
  • Rapporto con l'emittente: Non specificato nel testo del deposito.

Il Form 144 serve solo come preavviso; la transazione non è ancora avvenuta. Data la piccola entità rispetto al totale delle azioni, il deposito difficilmente eserciterà una pressione significativa sul mercato, ma offre un'indicazione sul sentimento recente degli insider.

Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) ha recibido un aviso Formulario 144 que indica que el insider Phillip Carrai tiene la intención de vender hasta 6.000 acciones ordinarias alrededor del 15 de julio de 2025 a través de Morgan Stanley Smith Barney. Según el precio de referencia del formulario, la transacción está valorada en aproximadamente 308.503,20 $.

Las acciones, originalmente emitidas como acciones restringidas el 4 de enero de 2022, representan aproximadamente el 0,004 % de las 153.443.342 acciones en circulación de la compañía, una cantidad demasiado pequeña para afectar el flotante o la liquidez. El formulario también detalla ventas de insiders en los últimos tres meses: 6.000 acciones el 16 de junio de 2025 por 252.967,20 $ y 6.000 acciones el 15 de mayo de 2025 por 202.356,00 $, sumando ventas declaradas de Carrai por 18.000 acciones en este trimestre.

  • Corredor: Morgan Stanley Smith Barney LLC, Nueva York.
  • Bolsa: NASDAQ.
  • Relación con el emisor: No especificada en el texto del formulario.

El Formulario 144 sirve solo como aviso previo; la transacción aún no ha ocurrido. Dado el pequeño tamaño en relación con el total de acciones, es poco probable que el formulario ejerza una presión significativa en el mercado, pero ofrece una visión sobre el sentimiento reciente de los insiders.

Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS)� 내부� Phillip Carrai가 Morgan Stanley Smith Barney� 통해 2025� 7� 15일경 최대 6,000� 보통�� 매도� 계획임을 알리� Form 144 통지� 받았습니�. 제출서류� 기준가격에 따르� � 거래 가치는 � 308,503.20 달러� 평가됩니�.

� 주식들은 원래 2022� 1� 4� 제한주식으로 발행되었으며, 회사� � 발행 주식� 153,443,342� � � 0.004%� 해당하는 소량으로, 유통 주식수나 유동성에 � 영향� 미치지 않습니다. 제출서류에는 최근 3개월� 내부� 매도 내역� 포함되어 있습니다: 2025� 6� 16일에 6,000�(252,967.20 달러), 2025� 5� 15일에 6,000�(202,356.00 달러) 매도하여 이번 분기 Carrai가 공개� 매도 주식은 � 18,000�입니�.

  • 중개�: Morgan Stanley Smith Barney LLC, 뉴욕.
  • 거래�: NASDAQ.
  • 발행인과� 관�: 제출서류� 명시되지 않음.

Form 144� 사전 통지� 불과하며, 거래� 아직 이루어지지 않았습니�. 전체 주식 대� 규모가 작아 시장� � 영향� 미칠 가능성은 낮지�, 최근 내부자의 심리� 엿볼 � 있는 자료입니�.

Kratos Defense & Security Solutions, Inc. (NASDAQ : KTOS) a reçu un avis Formulaire 144 indiquant que l'initié Phillip Carrai a l'intention de vendre jusqu'à 6 000 actions ordinaires aux alentours du 15 juillet 2025 via Morgan Stanley Smith Barney. Selon le prix de référence du dépôt, la transaction est évaluée à environ 308 503,20 $.

Les actions, initialement émises en tant qu'actions restreintes le 4 janvier 2022, représentent environ 0,004 % des 153 443 342 actions en circulation de la société, un montant trop faible pour affecter le flottant ou la liquidité. Le dépôt détaille également les ventes des initiés au cours des trois derniers mois : 6 000 actions le 16 juin 2025 pour 252 967,20 $ et 6 000 actions le 15 mai 2025 pour 202 356,00 $, portant les ventes déclarées de Carrai à 18 000 actions ce trimestre.

  • Intermédiaire : Morgan Stanley Smith Barney LLC, New York.
  • Bourse : NASDAQ.
  • Relation avec l'émetteur : Non spécifiée dans le texte du dépôt.

Le Formulaire 144 sert uniquement d'avis préalable ; la transaction n'a pas encore eu lieu. Étant donné la faible taille par rapport au total des actions, le dépôt est peu susceptible d'exercer une pression significative sur le marché, mais il offre un aperçu du sentiment récent des initiés.

Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) hat eine Form 144-Mitteilung erhalten, die darauf hinweist, dass Insider Phillip Carrai beabsichtigt, bis zu 6.000 Stammaktien etwa am 15. Juli 2025 über Morgan Stanley Smith Barney zu verkaufen. Basierend auf dem Referenzpreis der Meldung wird die Transaktion auf etwa 308.503,20 $ äٳ.

Die Aktien, ursprünglich als Restricted Stock am 4. Januar 2022 ausgegeben, machen etwa 0,004 % der 153.443.342 ausstehenden Aktien des Unternehmens aus � eine Menge, die zu gering ist, um den Streubesitz oder die Liquidität zu beeinflussen. Die Meldung enthält auch Insider-Verkäufe der letzten drei Monate: 6.000 Aktien am 16. Juni 2025 für 252.967,20 $ und 6.000 Aktien am 15. Mai 2025 für 202.356,00 $, womit Carrais gemeldete Verkäufe in diesem Quartal 18.000 Aktien betragen.

  • Makler: Morgan Stanley Smith Barney LLC, New York.
  • ö: NASDAQ.
  • Beziehung zum Emittenten: Im Meldungstext nicht angegeben.

Form 144 dient nur als Vorabmitteilung; die Transaktion hat noch nicht stattgefunden. Aufgrund der geringen Größe im Verhältnis zur Gesamtzahl der Aktien ist es unwahrscheinlich, dass die Meldung nennenswerten Marktdruck ausübt, bietet jedoch Einblick in die jüngste Insider-Stimmung.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Modi Rajeev A.

(Last) (First) (Middle)
C/O ELANCO ANIMAL HEALTH INCORPORATED
2500 INNOVATION WAY

(Street)
GREENFIELD IN 46140

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SEE REMARKS
3. Date of Earliest Transaction (Month/Day/Year)
07/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock Units (1) 07/11/2025 A 94.9409 (2) (2) Common Stock 94.9409 $14.9 6,555.6312 D
Explanation of Responses:
1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Remarks:
Executive Vice President U.S. Pet Health and Global Digital Transformation
/s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi 07/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Kratos (KTOS) Form 144 filed on July 15 2025 disclose?

It notifies the SEC that insider Phillip Carrai intends to sell up to 6,000 common shares valued at about $308,503.20.

How many KTOS shares has Phillip Carrai sold recently?

He sold 6,000 shares on May 15 2025 and 6,000 shares on June 16 2025, totaling 12,000 shares before the new 6,000-share notice.

What percentage of Kratos’s outstanding shares does the proposed sale represent?

Approximately 0.004 % of the 153,443,342 shares outstanding.

Which broker will handle the KTOS share sale?

Morgan Stanley Smith Barney LLC, Executive Financial Services, New York.

Does the Form 144 filing mean the sale has already occurred?

No. Form 144 is a notice of proposed sale; the transaction may or may not occur as scheduled.
Elanco Animal Health

NYSE:ELAN

ELAN Rankings

ELAN Latest News

ELAN Latest SEC Filings

ELAN Stock Data

7.46B
491.23M
0.88%
100.87%
2.92%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
United States
GREENFIELD